scientific Sessions

Cardiomyopathies and Sudden Death

This session from Heart World Conference (HWC) 2026 focuses on the clinical management of cardiomyopathies with an emphasis on the prevention of sudden cardiac death (SCD). It covers current approaches to genetic testing in hypertrophic, dilated, and arrhythmogenic cardiomyopathies, and their role in identifying at-risk individuals. Risk stratification tools—including advanced imaging, electrocardiographic markers, and family history—will be examined in the context of selecting patients for implantable cardioverter-defibrillator (ICD) therapy. The session also highlights the importance of individualized care pathways, early identification, and ongoing monitoring to reduce SCD risk in this population.

Related Sessions

Heart Failure
Congenital Heart Disease in Adults
Cardiomyopathies and Sudden Death
Preventive Cardiology and Hypertension
Neurocardiology
The Global Heart
Next Gen Cardiac Devices
Cardiovascular Health Across the Lifespan
Nanotechnology in Cardiovascular Disease
Sudden Cardiac Death
Technology and Innovation in Heart Health
Metabolism and the Heart
Cardio Oncology
Valvular Heart Disease
Arrhythmias and Electrophysiology
Coronary Artery Disease
Precision Cardiovascular Prevention
Cardiovascular Health in Motion
Cardiac Amyloidosis and Infiltrative Cardiomyopathies
Critical Care Cardiology
Don't miss our future updates!

Get in Touch